Low-density lipoproteins (LDL)—commonly known as bad cholesterol—have long been on scientists' radar as a major contributor ...

Neuropeutics Inc announces a collaboration with LifeArc to develop a new small molecule for the treatment of motor neuron disease (MND), also known as Amyotrophic Lateral Sclerosis (ALS). Tackling the ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...

Detailed price information for Promis Neurosciences Inc (PMN-Q) from The Globe and Mail including charting and trades.

Background/aims: Oro-pharyngeal dysfunction has been reported in Amyotrophic Lateral Sclerosis (ALS). We aimed to assess ALS patients upper gastrointestinal (GI) motor activity and GI symptoms ...

CSF: Cerebrospinal fluid; HHV: Human herpes virus; JCV: Polyomavirus JC; MeV: Measles virus; MS: Multiple sclerosis ... the CNS. Mechanisms Underlying the MS–virus Association Molecular mimicry ...

Molecular Mimicry: The Role of MAP2694 ... No writing assistance was utilized in the production of this manuscript. Multiple sclerosis (MS) is a complex disease, the etiology of which remains ...

Key Laboratory of Eutrophication and Red Tide Prevention of Guangdong Higher Education Institutes, College of Life Science and Technology, Jinan University, Guangzhou 510632, China ...

A University of California, Irvine-led research team has discovered intricate molecular mechanisms ... disorders such as amyotrophic lateral sclerosis, frontotemporal lobar dementia and ...